⏳ Fetching live dividend data...
Home › Calculator › BTHE Dividend Calculator 2026
Boston Therapeutics, Inc. · OTC
Price: $0.01 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
BTHE is not a dividend-focused stock
BTHE pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Boston Therapeutics, Inc. (BTHE) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
Founded in 2009 and headquartered in Lawrence, Massachusetts, Boston Therapeutics, Inc. operates as a pre-clinical and clinical-stage pharmaceutical development firm. The company specializes in the development, manufacturing, and commercialization of carbohydrate-based therapeutic drugs and dietary supplements within the United States. Its pipeline features several key drug candidates: BTI-320, a non-systemic carbohydrate compound currently in Phase IIb clinical trials, engineered to mitigate post-meal increases in blood glucose levels for patients with Type 2 diabetes and pre-diabetes; BTI-410, an injectable peptide compound that has completed Phase Ib clinical trials, developed for Type 1 immunosuppression therapy post-kidney transplant and for Type 2 diabetes patients; and IPOXYN, an injectable carbohydrate drug designed to prevent necrosis (cell death) and alleviate hypoxic conditions such as diabetic foot ulcers and other vascular/neurological complications. Furthermore, Boston Therapeutics markets SUGARDOWN, a non-systemic complex carbohydrate dietary supplement supporting healthy post-meal blood glucose levels. The company previously operated as Avanyx Therapeutics, Inc. before adopting its current name in November 2010.
No. Boston Therapeutics, Inc. (BTHE) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
A DRIP reinvests dividends into new shares. BTHE has no regular dividend in our data, so there is nothing to reinvest.
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BTHE position with:
Real after-tax yield depends on where you live and how you hold BTHE.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
BTHE pays quarterly — 4 times per year. Ex-div: —.
How BTHE compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BTHE sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2018-02-02 | 2,000,000 | $0.15 | $300.0K | ||
| Buy | 2018-02-02 | 1,000,000 | $0.10 | $100.0K | ||
| Other | 2011-09-15 | 1,500,000 | $0.10 | $150.0K | ||
| Other | 2016-08-12 | 6,000,000 | $0.20 | $1.20M | ||
| Other | 2015-03-25 | 500,000 | $0.18 | $90.0K | ||
| Buy | 2015-05-15 | 5,000 | $0.12 | $600.00 | ||
| Buy | 2015-05-15 | 1,000 | $0.15 | $148.00 | ||
| Buy | 2015-05-14 | 5,000 | $0.12 | $600.00 | ||
| A-Award | 2014-09-25 | 6,000 | $0.37 | $2.2K | ||
| Buy | 2015-03-18 | 9,000 | $0.20 | $1.8K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Compare BTHE with peers: BTHE vs AVEFF · BTHE vs BNOEF · BTHE vs FLWPF
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BTHE dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Boston Therapeutics, Inc. (BTHE) is currently trading at $0.01, 16% below its 52-week high. It does not currently pay a regular dividend.
Boston Therapeutics, Inc. (BTHE) is a healthcare stock trading at $0.01. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
Auto-generated from live market data. For educational purposes only — not financial advice.
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever